SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Hepion Says GV104 Prevented Fentanyl-Induced Cardiac Arrest in 200-Subject Simulation

Hepion reported that its GV104 treatment prevented fentanyl-induced cardiac arrest in a simulation involving 200 subjects.

HEPA

Related stories